文献速递肝胆胰外科围术期管理与 ERAS

胰腺血管手术中血管导管的临床结局、手术技术与移植物性能分析

Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques, and Graft Performance.
PubMed 文献 · Ann Surg · 2022-07-15

中位术后生存2年,Clavien-Dindo≥IIIa并发症占50%,中位综合并发症指数29.6,90天死亡率9%。导管影像学通畅率术后30天和90天分别为66%和45%。

要点

  • 血管胰腺手术中导管重建的90天死亡率为9%,技术可行。
  • Clavien-Dindo≥IIIa并发症占50%,中位综合并发症指数29.6。
  • 导管通畅率术后30天66%、90天45%,早期闭塞预测因素仍具挑战。

核心结论

  • 动脉或静脉系统导管重建的围术期死亡率为9%,技术可行但早期导管闭塞预测因素尚不明确。

主要发现

  • 中位术后生存2年,Clavien-Dindo≥IIIa并发症占50%,中位综合并发症指数29.6,90天死亡率9%。
  • 死亡原因中导管相关3例、迟发性胰腺切除术后出血1例、早期肝转移1例。
  • 导管影像学通畅率术后30天为66%,术后90天为45%。

临床怎么用

  • 在高选择胰腺癌患者中可考虑导管重建,需注意较高的严重并发症风险和早期导管闭塞可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We analyze successes and failures of pushing the boundaries in vascular pancreatic surgery to establish safety of conduit reconstructions. BACKGROUND: Improved systemic control from chemotherapy in pancreatic cancer is increasing the demand for surgical solutions of extensive local vessel involvement, but conduit-specific data are scarce. METHODS: We identified 63 implanted conduits (41% autologous vessels, 37% allografts, 18% PTFE) in 56 pancreatic resections of highly selected cancer patients between October 2013 and July 2020 from our prospectively maintained database. Assessed parameters were survival, perioperative complications, operative techniques (anatomic and extra-anatomic routes), and conduit patency. RESULTS: For vascular reconstruction, 25 arterial and 38 venous conduits were utilized during 39 pancreatoduodenectomies, 14 distal pancreatectomies, and 3 total pancreatectomies. The median postoperative survival was 2 years. A Clavien-Dindo grade ≥IIIa complication was apparent in 50% of the patients with a median Comprehensive Complication Index of 29.6. The 90-day mortality in this highly selected cohort was 9%. Causes of mortality were conduit related in 3 patients, late postpancreatectomy hemorrhage in 1 patient, and early liver metastasis in 1 patient. Image-based patency rates of conduits were 66% and 45% at postoperative days 30 and 90, respectively. CONCLUSIONS: Our perioperative mortality of vascular pancreatic surgery with conduits in the arterial or venous system is 9%. Reconstructions are technically feasible with different anatomic and extra-anatomic strategies, while identifying predictors of early conduit occlusion remains challenging. Optimizing reconstructed arterial and venous hemodynamics in the context of pancreatic malignancy will enable long-term survival in more patients responsive to chemotherapies.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kinny-Köster B, Habib JR, van Oosten F, et al. Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques, and Graft Performance. Ann Surg. 2022. PMID: 35838419. doi:10.1097/SLA.0000000000005575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。